We are thrilled to announce that Cartesian Therapeutics has successfully raised $130,000,000 in funding to further advance its groundbreaking RNA cell therapy for autoimmune disease treatment. Following the merger with Selecta Biosciences Inc., Cartesian Therapeutics is now a publicly traded company at the forefront of innovative medical solutions. The funding will support the development and progression of Descartes-08, the company鈥檚 lead product candidate currently in clinical trials for autoimmune conditions like myasthenia gravis. This significant investment underscores the confidence in Cartesian Therapeutics' pioneering approach to revolutionize the treatment of autoimmune diseases. To stay updated on the company's progress and developments, please visit https://www.cartesiantherapeutics.com/ or connect with us on LinkedIn @Cartesian-Therapeutics.
Pioneering RNA Cell Therapy: Cartesian Therapeutics Secures $130M in Funding
Recently funded 路 $130.0MBiotechnology
Get the full Cartesian Therapeutics company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
$1.5M Pre-seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
